montelukast and Panniculitis--Nodular-Nonsuppurative

montelukast has been researched along with Panniculitis--Nodular-Nonsuppurative* in 1 studies

Other Studies

1 other study(ies) available for montelukast and Panniculitis--Nodular-Nonsuppurative

ArticleYear
Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents.
    Mayo Clinic proceedings, 2000, Volume: 75, Issue:6

    Leukotriene-modifying drugs are novel agents introduced recently to treat asthma. Both 5-lipoxygenase inhibitors, such as zileuton, and leukotriene receptor antagonists, such as zafirlukast and montelukast, have proved effective in the treatment of asthma. To our knowledge, there have been no detailed reports regarding dermatologic manifestations of this class of drugs. This article describes an unusual case of erythema nodosum in a 46-year-old asthmatic man who received 2 different leukotriene modifiers.

    Topics: Acetates; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Cyclopropanes; Diagnosis, Differential; Erythema Induratum; Humans; Hydroxyurea; Leukotriene Antagonists; Lipoxygenase Inhibitors; Male; Middle Aged; Panniculitis, Nodular Nonsuppurative; Quinolines; Sulfides

2000